2nd Berlin Conference on IP in Life Sciences 2009: From Biomarkers to Diagnostics

Biomarkers are used throughout the healthcare sector, from biological research laboratories to clinical patient monitoring. Biomarker diagnostics and drug therapy combinations form the basis for the next generation of effective and useful treatments for a broad spectrum of diseases.

The 2nd Berlin Conference on IP in Life Sciences aimed to address nearly every aspect of diagnostics development, focusing on the entire value chain from research and development to marketing and reimbursement. Leading European life science experts from industry and research, biobanks, contract research and regulators were represented at the conference, which was specifically tailored for biotech and pharmaceutical companies.